Nanomerics proudly announces its continuous participation as an industry partner in the Royal Society of Chemistry's (RSC) Broadening Horizons in the Chemical Sciences programme. Nanomerics has been an industry partner since the launch of the programme in 2022 and is one of the founding partners. The Broadening Horizons initiative aims to support and engage the next generation of scientists from ethnic minority backgrounds and enable these scientists to pursue careers in the chemical sciences. Engagement is achieved by offering access to mentoring, networking and opportunities to gain industry experience.
In June, Nanomerics welcomed the programme’s third cohort at the taster event organised by the RSC in Manchester. During the event, Nanomerics representatives showcased the company's ground-breaking research and development activities and award-winning Molecular Envelope Technology (MET). Nanomerics’ MET is positioned to offer unprecedented healthcare benefits to patients. Formulations that target neurology and eye care are currently in development. Over 100 participants had the opportunity to engage directly with the Nanomerics’ team, gaining first-hand knowledge about the practical application of chemistry in the pharmaceutical industry. Participants also gained insights into a variety of career pathways within this rapidly evolving sector.
By collaborating with the RSC on this important initiative, Nanomerics aims to encourage the programme’s participants to explore the multifaceted opportunities available in the industrial pharmaceutical sciences. As a leader in nanomedicine and advanced drug delivery technologies, Nanomerics is committed to transforming healthcare through innovative research, as well as building and cultivating an inclusive and diverse environment that nurtures future talent in the sector. We are excited to contribute to the professional growth of students and early-career scientists, paving the way for future innovators to offer new medicines to patients.
Comments